期刊文献+

神经末端B型脑钠肽原的检测在老年慢性心力衰竭诊断中的应用 被引量:6

NT-proBNP peptide in elderly patients with chronic heart failure
暂未订购
导出
摘要 目的观察老年慢性心力衰竭患者血浆中N末端B型脑钠肽原(NT-proBNP)的浓度变化。方法选择心功能Ⅱ-Ⅳ级老年慢性心力衰竭患者120例作为观察组,选择正常体检老年人110例作为对照组。用德国进口技术的POCT仪器测量所有患者的血浆NT-proBNP浓度,并根据实际情况进行纽约心脏病协会(NYHA)心功能分级。结果老年慢性心力衰竭组的NT-proBNP较对照组明显升高,且随着心功能分级的升高NT-proBNP逐渐增加,差异有统计学意义(P〈0.05)。结论检测血浆NT-proBNP是诊断老年慢性心力衰竭的可靠化验指标。并且与心功能的严重程度关系密切。动态监测老年慢性心力衰竭患者血浆NT-proBNP的变化可有效评估患者的预后。 Objective To observe N-terminal B-type natriuretic peptide (NT-proBNP) in elderly patients with chronic heart failure. Methods 120 patients with chronic heart failure class Ⅱ-Ⅳ were selected as the observation group and controlled with 110 people with physical examination. The serum NT-proBNP was detected with Germany imported technology POCT instruments. The heart function was classified with New York Heart Association (NYHA) Heart As- sociation functional class. Results The NT-proBNP of elderly patients with chronic heart failure was significantly higher than that of the control group(P〈0.05). Conclusion Detection of plasma NT-proBNP is a reliable indicator for the di- agnosis of chronic heart failure, and is closely related to the severity of heart failure. Dynamic observation of plasma NT- proBNP level changes can effectively determine the prognosis of patients.
机构地区 昌黎县人民医院
出处 《西部医学》 2014年第3期308-309,313,共3页 Medical Journal of West China
基金 秦皇岛市科研基金项目(2012023A236)
关键词 N末端B型脑钠肽原 老年人 慢性心力衰竭 N-terminal B-type brain natriuretic peptide Old ages Chronic heart failure
  • 相关文献

参考文献5

二级参考文献31

共引文献53

同被引文献56

  • 1姜红,葛均波.心力衰竭流行病学特点[J].中国医学前沿杂志(电子版),2010,2(1):1-5. 被引量:92
  • 2王蓉.进行血NT-proBNP及尿酸联合检测在诊断老年慢性心力衰竭方面的临床价值分析[J].当代医药论丛,2014,12(6):59-60. 被引量:8
  • 3刘军锋,贾克刚,刘运德.B型钠尿肽检测在心血管疾病中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(6):352-354. 被引量:25
  • 4Yancy CW,Saltzberg MT,Berkowitz RL,ei al. Safety and feasi-bility of using serial infusions of nesiritide for heart failure in anoutpatient setting (from the FUSION I trial)[J]. Am J Cardiol,2004,94(5):595-601.
  • 5Nieminer MS, Bohm M,Cowie MR, et al. Executive summaryof the guidelines on the diagnosis and treatment of acute HeartFailure of the European Society of Cardiology [J]. Eur Heart J,2005,26C4):384-416.
  • 6Shah SJ , Michaels AD. Acute effects of intravenous nesiritide oncardiac contractility in heart failure[J]. J Cardiac Fail,2010,16 :720-727.
  • 7Kogler H,Schott P, Toischer K, et al. Revalence of brain natri-uretic peptide in preload-dependent regulation of cardiac sarco-plasmic reticulum Ca2+ ATPase expression [ J]. Circulation,2006,113: 2724-2732.
  • 8Hori M, Nagai R, Izumi T, et al. Efficacy and safety of bisoprol- ol fumarate compared with carvedilol in Japanese patients with chronic heart failure: Results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol in Chronic Heart Failure II (MAIN-CHF II) study [J]. Heart and vessels: An international iournal, 2014,29 (2) : 238-247.
  • 9吴少平,洪鹭蓉,周秀文.B型钠尿肽对心力衰竭的临床应用价值[J].实用心脑肺血管病杂志,2008,16(11):54-55. 被引量:6
  • 10戴敏,杨俊华,周炳元,王如兴,羊镇宇,吴小庆.应用心衰超声指数评价慢性心力衰竭患者的临床价值[J].实用医学杂志,2009,25(12):1972-1974. 被引量:30

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部